Molecular therapies for HCC: Looking outside the box
Faivre, Sandrine, Rimassa, Lorenza, Finn, Richard S.
Published in Journal of hepatology (01.02.2020)
Published in Journal of hepatology (01.02.2020)
Get full text
Journal Article
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, Josep M, Montal, Robert, Sia, Daniela, Finn, Richard S
Published in Nature reviews. Clinical oncology (01.10.2018)
Published in Nature reviews. Clinical oncology (01.10.2018)
Get full text
Journal Article
Treating cancer with selective CDK4/6 inhibitors
O'Leary, Ben, Finn, Richard S, Turner, Nicholas C
Published in Nature reviews. Clinical oncology (01.07.2016)
Published in Nature reviews. Clinical oncology (01.07.2016)
Get full text
Journal Article
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
Cheng, Ann-Lii, Qin, Shukui, Ikeda, Masafumi, Galle, Peter R., Ducreux, Michel, Kim, Tae-You, Lim, Ho Yeong, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed O., Li, Daneng, Verret, Wendy, Ma, Ning, Nicholas, Alan, Wang, Yifan, Li, Lindong, Zhu, Andrew X., Finn, Richard S.
Published in Journal of hepatology (01.04.2022)
Published in Journal of hepatology (01.04.2022)
Get full text
Journal Article
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Finn, Richard S, Ryoo, Baek-Yeol, Merle, Philippe, Kudo, Masatoshi, Bouattour, Mohamed, Lim, Ho Yeong, Breder, Valeriy, Edeline, Julien, Chao, Yee, Ogasawara, Sadahisa, Yau, Thomas, Garrido, Marcelo, Chan, Stephen L, Knox, Jennifer, Daniele, Bruno, Ebbinghaus, Scot W, Chen, Erluo, Siegel, Abby B, Zhu, Andrew X, Cheng, Ann-Lii
Published in Journal of clinical oncology (20.01.2020)
Published in Journal of clinical oncology (20.01.2020)
Get full text
Journal Article
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Galle, Peter R, Ducreux, Michel, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed O, Li, Daneng, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Liu, Juan, Huang, Chen, Mulla, Sohail, Wang, Yulei, Lim, Ho Yeong, Zhu, Andrew X, Cheng, Ann-Lii
Published in The New England journal of medicine (14.05.2020)
Published in The New England journal of medicine (14.05.2020)
Get full text
Journal Article
Hepatocellular carcinoma
Llovet, Josep M, Kelley, Robin Kate, Villanueva, Augusto, Singal, Amit G, Pikarsky, Eli, Roayaie, Sasan, Lencioni, Riccardo, Koike, Kazuhiko, Zucman-Rossi, Jessica, Finn, Richard S
Published in Nature reviews. Disease primers (21.01.2021)
Published in Nature reviews. Disease primers (21.01.2021)
Get full text
Journal Article
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
Yau, Thomas, Park, Joong-Won, Finn, Richard S, Cheng, Ann-Lii, Mathurin, Philippe, Edeline, Julien, Kudo, Masatoshi, Harding, James J, Merle, Philippe, Rosmorduc, Olivier, Wyrwicz, Lucjan, Schott, Eckart, Choo, Su Pin, Kelley, Robin Kate, Sieghart, Wolfgang, Assenat, Eric, Zaucha, Renata, Furuse, Junji, Abou-Alfa, Ghassan K, El-Khoueiry, Anthony B, Melero, Ignacio, Begic, Damir, Chen, Gong, Neely, Jaclyn, Wisniewski, Tami, Tschaika, Marina, Sangro, Bruno
Published in The lancet oncology (01.01.2022)
Published in The lancet oncology (01.01.2022)
Get full text
Journal Article
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
Finn, Richard S, Aleshin, Alexey, Slamon, Dennis J
Published in Breast cancer research : BCR (09.02.2016)
Published in Breast cancer research : BCR (09.02.2016)
Get full text
Journal Article
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Llovet, Josep M, Villanueva, Augusto, Lachenmayer, Anja, Finn, Richard S
Published in Nature reviews. Clinical oncology (01.07.2015)
Published in Nature reviews. Clinical oncology (01.07.2015)
Get full text
Journal Article
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Zhu, Andrew X, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Galle, Peter R, Llovet, Josep M, Assenat, Eric, Brandi, Giovanni, Pracht, Marc, Lim, Ho Yeong, Rau, Kun-Ming, Motomura, Kenta, Ohno, Izumi, Merle, Philippe, Daniele, Bruno, Shin, Dong Bok, Gerken, Guido, Borg, Christophe, Hiriart, Jean-Baptiste, Okusaka, Takuji, Morimoto, Manabu, Hsu, Yanzhi, Abada, Paolo B, Kudo, Masatoshi
Published in The lancet oncology (01.02.2019)
Published in The lancet oncology (01.02.2019)
Get full text
Journal Article
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Marrero, Jorge A., Kulik, Laura M., Sirlin, Claude B., Zhu, Andrew X., Finn, Richard S., Abecassis, Michael M., Roberts, Lewis R., Heimbach, Julie K.
Published in Hepatology (Baltimore, Md.) (01.08.2018)
Published in Hepatology (Baltimore, Md.) (01.08.2018)
Get full text
Journal Article
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Finn, Richard S., Merle, Philippe, Granito, Alessandro, Huang, Yi-Hsiang, Bodoky, György, Pracht, Marc, Yokosuka, Osamu, Rosmorduc, Olivier, Gerolami, René, Caparello, Chiara, Cabrera, Roniel, Chang, Charissa, Sun, Weijing, LeBerre, Marie-Aude, Baumhauer, Annette, Meinhardt, Gerold, Bruix, Jordi
Published in Journal of hepatology (01.08.2018)
Published in Journal of hepatology (01.08.2018)
Get full text
Journal Article
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
Galle, Peter R, Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Zhu, Andrew X, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed, Li, Daneng, Mulla, Sohail, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Ding, Beiying, Liu, Juan, Huang, Chen, Lim, Ho Yeong, Cheng, Ann-Lii, Ducreux, Michel
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article
The Role of Angiogenesis in Hepatocellular Carcinoma
Morse, Michael A, Sun, Weijing, Kim, Richard, He, Aiwu Ruth, Abada, Paolo B, Mynderse, Michelle, Finn, Richard S
Published in Clinical cancer research (01.02.2019)
Published in Clinical cancer research (01.02.2019)
Get full text
Journal Article
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Teufel, Michael, Seidel, Henrik, Köchert, Karl, Meinhardt, Gerold, Finn, Richard S., Llovet, Josep M., Bruix, Jordi
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Get full text
Journal Article
Immunotherapies for hepatocellular carcinoma
Llovet, Josep M, Castet, Florian, Heikenwalder, Mathias, Maini, Mala K, Mazzaferro, Vincenzo, Pinato, David J, Pikarsky, Eli, Zhu, Andrew X, Finn, Richard S
Published in Nature reviews. Clinical oncology (01.03.2022)
Published in Nature reviews. Clinical oncology (01.03.2022)
Get full text
Journal Article